ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

With Access To $20 Million In Financing, 1606 Corp Is Eyeing CBD Business Acquisitions As It Embarks On An Aggressive Growth Path

--News Direct--

By Ernest Dela Aglanu, Benzinga

The global CBD market is on an upward trajectory, and there are no indications that the growth could be slowing down anytime soon. The market was valued at $5.18 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 16.8% from 2022 to 2030.

The positive growth projections could be good news for industry watchers and players like 1606 Corp (OTC: CBDW), which plans to accumulate a diverse portfolio of cannabidiol (CBD) products and companies nationwide by consolidating the fragmented CBD industry via acquisitions.

Due to the numerous benefits of CBD, including treating anxiety and seizures and reducing pain, there is growing demand for health and wellness purposes. This ever-increasing demand and rising acceptance and use of CBD products thanks to increasingly friendly government regulations could significantly benefit a player like 1606.

$20 Million Financing For CBD Businesses Acquisition

The company, in line with its growth plans, recently revealed on February 16 that it had secured $20 million in financing to acquire CBD businesses after entering into an Equity Financing Agreement. (8-K)

“We’re moving fast. Now that we have our feet underneath us since receiving the ticker symbol CBDW and now we’re taking definitive steps toward adding shareholder value. This $20 million financing is going to allow us to buy profitable CBD companies, and we’ll be a great investment opportunity for investors around the world,” Greg Lambrecht, CEO and Chairman of 1606 Corp, said.

In the next six to 18 months, the company aims to spend between $5 million to $20 million on acquiring established brands or a broad spectrum of companies that are into CCBD + hemp edibles and topicals that are about six years old. While 1606 didn’t divulge any specifics, they did say they are waiting on a signature to close an acquisition any day now.

Compared to other players like Canopy Growth Corp. (NASDAQ: CGC), Jazz Pharmaceuticals PLC (NASDAQ: JAZZ), Nandan Denim Ltd. (NSE: NDL), and Aurora Cannabis Inc. (NASDAQ: ACB), the company’s difference and power with its acquisition war chest could be key, especially as it is able to act while valuations are attractive and push forward into the future of the industry.

The Phoenix, Arizona-based company, which began trading on the OTC Market on January 17, is known to acquire and develop CBD brands, including Truz and CBD Singlez, with the aim of consolidating the fragmented CBD industry.

Production Of New Inventory Of CBD Smokables To Supply 2500 Retail Outlets

To actively engaged in a modern direct marketing campaign to continue the growth into individual retail stores, 1606 has hired a direct marketing industry veteran, Brent Duskin. He is expected to increase the company’s product footprints in more retail locations in the U.S.

According to a statement by the company, Mr. Duskin has worked with Fortune 500 companies that complement CEO Greg Lambrecht’s experience and connections in retail distribution. Mr. Lambrecht has personally conducted business with over 30,000 retail stores in his career and is the foundation of the recent growth of 1606 CBD products.

The company’s main product skew is CBD Singlz, a smokable CDB product. The displays hold three 25ct Singlz containing mango-flavored CBD rolls, Original Flavor, and Menthol. These products are enthusiastically being used by cigarette smokers to quit their addiction to nicotine.

1606 reports that it currently has enough inventory to fill orders for an additional 2500 retail locations.

"The gap left as a result of the flavor ban on vaping and tobacco products has resulted in a lot of shelves being open, and we're aggressively taking advantage of that opportunity. The fact that the Federal Government will not be adding regulations to the CBD industry leads us to believe that the time is right now for the consolidation of the industry, and that’s why we’re excited to have a $20,000,000 opportunity in the next year to execute on that ideal," said Greg Lambrecht - CEO & Chairman of 1606 Corp (OTC | CBDW).

For CBD business inquiries contact: acquisitions@cbd.inc.

This article was originally published on Benzinga here.

1606 Corp acquires and develops CBD brands including Truz and CBD Singlez, (www.1606hemp.com). The company utilizes an acquisition model aimed at consolidating the fragmented CBD industry. 1606 Corp has a primary focus on Hemp and CBD products, brand development, and establishing distribution channels. 1606 Corp. was awarded the ticker symbol CBDW on January 1th, 2022 and began trading on the OTC Market on January 17th, 2023.

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Contact Details

Greg Lambrecht

greg@1606corp.com

Company Website

https://cbd.inc/

View source version on newsdirect.com: https://newsdirect.com/news/with-access-to-20-million-in-financing-1606-corp-is-eyeing-cbd-business-acquisitions-as-it-embarks-on-an-aggressive-growth-path-984084310

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.